A US federal judge has ordered the Pentagon to explain medical differences in testosterone therapy for transgender service members versus other troops. The request comes amid a legal challenge to the military's policy on transgender personnel.
Detailed Coverage
US District Judge Ana Reyes has issued a directive requiring the Pentagon to clarify its medical guidelines regarding testosterone replacement therapy. The court is examining how treatment protocols for transgender service members compare to those provided to other military personnel. This judicial inquiry is part of an ongoing legal challenge concerning the policy that restricts transgender individuals from serving in the US military.
Impact of New Testosterone Screening Program
The court's request follows a recent announcement by Defense Secretary Pete Hegseth regarding a new initiative to screen military personnel for low testosterone levels. Under this program, troops aged 30 and older will undergo mandatory annual screenings for testosterone deficiency, while voluntary testing will be offered to those under the age of 30. The Pentagon has stated that any subsequent treatment provided under this initiative will be voluntary.
Judicial Review of Policy Consistency
Judge Reyes is focusing on the potential contradictions between this new screening initiative and the existing military ban on transgender individuals. The current policy, which remains in effect following US Supreme Court approval, cites the need for high mental and physical health standards and limits the use of special medical provisions. The court is now asking the Department of Defense to provide a formal rationale for why it distinguishes between the testosterone therapy needs of transgender men and the therapy offered to other service members.
Legal Context and Ongoing Proceedings
This case, which has been granted class-action status, involves active-duty transgender service members and former personnel who are seeking to reenlist. While the Supreme Court has allowed the government to continue enforcing the service ban during the litigation process, Judge Reyes’ latest order brings renewed focus to the military's internal medical policies. The court’s next steps will involve reviewing the medical and logistical data submitted by both parties to determine if the department’s approach creates an inequitable standard for different groups within the service.